106 related articles for article (PubMed ID: 30519316)
1.
Ying Y; Xu J; Qi Y; Zhang M; Yang Y
J Cancer; 2018; 9(22):4166-4171. PubMed ID: 30519316
[No Abstract] [Full Text] [Related]
2.
Cai J; Ye Q; Luo S; Zhuang Z; He K; Zhuo ZJ; Wan X; Cheng J
Oncotarget; 2017 Aug; 8(34):56780-56790. PubMed ID: 28915630
[TBL] [Abstract][Full Text] [Related]
3. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
4. Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
Shih LC; Tsai CW; Sun KT; Hsu HM; Shen TC; Tsai YT; Chang WS; Lin ML; Wang YC; Gong CL; Bau DT
In Vivo; 2019; 33(4):1151-1156. PubMed ID: 31280204
[TBL] [Abstract][Full Text] [Related]
5. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
[TBL] [Abstract][Full Text] [Related]
6. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
Wu MH; Hung YW; Gong CL; Chao CC; Yueh TC; Wang SC; Lai YL; Hsu SW; Fu CK; Wang YC; Ke TW; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2019 Jun; 39(6):2791-2797. PubMed ID: 31177115
[TBL] [Abstract][Full Text] [Related]
8. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
9. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
Li Z; Wang J; Wang F; Ma Z; Yu Z
Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
[TBL] [Abstract][Full Text] [Related]
10. Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study.
Pardini B; Verderio P; Pizzamiglio S; Nici C; Maiorana MV; Naccarati A; Vodickova L; Vymetalkova V; Veneroni S; Daidone MG; Ravagnani F; Bianchi T; Bujanda L; Carracedo A; Castells A; Ruiz-Ponte C; Morreau H; Howarth K; Jones A; Castellví-Bel S; Li L; Tomlinson I; Van Wezel T; Vodicka P; Radice P; Peterlongo P;
PLoS One; 2014; 9(1):e85538. PubMed ID: 24465592
[TBL] [Abstract][Full Text] [Related]
11. A six-nucleotide deletion polymorphism in the casp8 promoter is associated with reduced risk of esophageal and gastric cancers in Kashmir valley.
Malik MA; Zargar SA; Mittal B
Indian J Hum Genet; 2011 Sep; 17(3):152-6. PubMed ID: 22345985
[TBL] [Abstract][Full Text] [Related]
12. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
13. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
15. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
16. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer.
Wang M; Zhang Z; Tian Y; Shao J; Zhang Z
Clin Cancer Res; 2009 Apr; 15(7):2567-72. PubMed ID: 19276244
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.
Du H; Song GX; Fang MZ; Shu YQ; Zhao X; Zhu LJ
J Biomed Res; 2019 Jun; 33(3):173-180. PubMed ID: 30057371
[TBL] [Abstract][Full Text] [Related]
18. CASP-8 -652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis.
Chen D; Ma T; Liu XW; Liu Z
Exp Ther Med; 2012 Oct; 4(4):762-770. PubMed ID: 23170140
[TBL] [Abstract][Full Text] [Related]
19. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
[TBL] [Abstract][Full Text] [Related]
20.
Liu X; Huang J; Lin H; Xiong L; Ma Y; Lao H
J Cancer; 2018; 9(16):2963-2972. PubMed ID: 30123365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
